Quarterly report pursuant to Section 13 or 15(d)

Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details)

v3.23.3
Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details) - shares
shares in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 572 370
Outstanding Options to Purchase Common Stock [Membe    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 559 350
Warrants to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 13 20